The impact of epidermal-growth-factor-receptor mutations in response to lung-cancer therapy

被引：0
|
作者：
Jonathan E Dowell
John D Minna
机构：
[1] University of Texas Southwestern Medical Center,Director of Hamon Center for Therapeutic Oncology Research and a Professor in the Departments of Internal Medicine and Pharmacology
[2] Chief of Hematology and Oncology at the Dallas Veterans Affairs Medical Center,undefined
来源：
Nature Clinical Practice Oncology | 2004年 / 1卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Non-small-cell lung cancer is the leading cause of cancer death in the US despite advances in therapy. The epidermal-growth-factor receptor has been investigated as a target for therapy using EGFR-specific tyrosine kinase inhibitors. This Viewpoint discusses the implications of the correlation of positive responses seen in patients harboringEGFRmutations.
引用
收藏
页码：2 / 3
页数：1
相关论文
共 50 条
  • [21] Selection and characterization of an internalizing epidermal-growth-factor-receptor antibody
    Zhao, Xiaorong
    Dai, Wentao
    Cao, Limin
    Zhu, Huifen
    Yu, Yihan
    Ye, Qing
    Wang, Min
    Dai, Wei
    Lei, Ping
    Shen, Guanxin
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2007, 46 : 27 - 33
  • [22] mRNA expression of ligands of the epidermal-growth-factor-receptor in the uterus
    Pfeiffer, D
    Spranger, J
    AlDeiri, M
    Kimmig, R
    FisselerEckhoff, A
    Scheidel, P
    Schatz, H
    Jensen, A
    Pfeiffer, A
    INTERNATIONAL JOURNAL OF CANCER, 1997, 72 (04) : 581 - 586
  • [23] Impact of age on epidermal growth factor receptor mutation in lung cancer
    Ueno, Tsuyoshi
    Toyooka, Shinichi
    Suda, Kenichi
    Soh, Junichi
    Yatabe, Yasushi
    Miyoshi, Shinichiro
    Matsuo, Keitaro
    Mitsudomi, Tetsuya
    LUNG CANCER, 2012, 78 (03) : 207 - 211
  • [24] Humoral immune response to epidermal growth factor receptor in lung cancer
    Yulin Wang
    Fenghui Liu
    Songyun OuYang
    Man Liu
    Xue Zhang
    Peng Wang
    Chunling Zhao
    Liguo Zhang
    Liping Dai
    Immunologic Research, 2021, 69 : 71 - 80
  • [25] Humoral immune response to epidermal growth factor receptor in lung cancer
    Wang, Yulin
    Liu, Fenghui
    OuYang, Songyun
    Liu, Man
    Zhang, Xue
    Wang, Peng
    Zhao, Chunling
    Zhang, Liguo
    Dai, Liping
    IMMUNOLOGIC RESEARCH, 2021, 69 (01) : 71 - 80
  • [26] Mutations and Response to Epidermal Growth Factor Receptor Inhibitors
    Laurent-Puig, Pierre
    Lievre, Astrid
    Blons, Helene
    CLINICAL CANCER RESEARCH, 2009, 15 (04) : 1133 - 1139
  • [27] EXON 20 MUTATIONS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) IN LUNG ADENOCARCINOMAS: CLINICOPATHOLOGIC FACTORS AND RESPONSE TO THERAPY
    Naidoo, J.
    Sima, C. S.
    Hellmann, M. D.
    Arcila, M. E.
    Rizvi, N. A.
    Yu, H. A.
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : S40 - S40
  • [28] Chasing mutations in the epidermal growth factor in lung cancer
    Dowell, JE
    Minna, JD
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (08): : 830 - 832
  • [29] Targeted therapy in non-small cell lung cancer: a focus on epidermal growth factor receptor mutations
    Milano, Gerard A.
    CHINESE CLINICAL ONCOLOGY, 2015, 4 (04)
  • [30] Timing of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Patients With Lung Cancer With EGFR Mutations
    Moran, Teresa
    Sequist, Lecia V.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27) : 3330 - 3336
12345